Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients
Authors
Keywords
Cryocare cryoablation, Carbohydrate antigen, Carcinoembryonic antigen, Tumor-specific growth factor, Pancreatic cancer
Journal
CELL BIOCHEMISTRY AND BIOPHYSICS
Volume 71, Issue 3, Pages 1287-1291
Publisher
Springer Nature
Online
2014-12-08
DOI
10.1007/s12013-014-0345-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differentially Expressed miRNAs in Cancer-Stem-Like Cells: Markers for Tumor Cell Aggressiveness of Pancreatic Cancer
- (2014) Bin Bao et al. STEM CELLS AND DEVELOPMENT
- Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer
- (2014) Xueyan Li et al. TUMOR BIOLOGY
- Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis
- (2014) Zhe Huang et al. TUMOR BIOLOGY
- Prognostic significance of SUVmax and serum carbohydrate antigen 19-9 in pancreatic cancer
- (2014) Jian-Guo Zhao WORLD JOURNAL OF GASTROENTEROLOGY
- CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis
- (2013) Ji-Cong Gui et al. CLINICAL AND EXPERIMENTAL MEDICINE
- The combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients
- (2013) Mitsuro Kanda et al. SURGERY TODAY
- Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
- (2013) Ching-Wei D. Tzeng et al. HPB
- Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy
- (2013) Uwe Pelzer et al. Frontiers in Oncology
- Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patients
- (2012) Gang Zhou et al. BIOTECHNOLOGY LETTERS
- Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy
- (2012) Todd M. Bauer et al. CANCER
- Prognostic Significance of Carbohydrate Antigen 19-9 in Unresectable Locally Advanced Pancreatic Cancer Treated With Dose-Escalated Intensity Modulated Radiation Therapy and Concurrent Full-Dose Gemcitabine: Analysis of a Prospective Phase 1/2 Dose Escalation Study
- (2012) Jeffrey M. Vainshtein et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Neutrophil Gelatinase-Associated Lipocalin, Macrophage Inhibitory Cytokine 1, and Carbohydrate Antigen 19-9 in Pancreatic Juice
- (2012) Sukhwinder Kaur et al. PANCREAS
- The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma
- (2011) Sundeep Singh et al. DIGESTIVE DISEASES AND SCIENCES
- Pretreatment Carbohydrate Antigen 19-9 Level Indicates Tumor Response, Early Distant Metastasis, Overall Survival, and Therapeutic Selection in Localized and Unresectable Pancreatic Cancer
- (2011) Tae Yoo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now